Late Breaking Lab News
May 16, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Chalk up another lab outreach deal for Labcorp. The Burlington, N.C.-based company has agreed to acquire certain assets of AtlantiCare’s clinical laboratory outreach business. The deal was announced on May 9, with no financial terms disclosed. The outreach business of AtlantiCare, bas…
April 25, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
In a sign that awareness of medical diagnostic testing continues to grow during the SARS-CoV-2 pandemic, the Mayo Clinic announced it will invest $49 million to build a new laboratory space on its campus in Rochester, Minn. As part of the multi-year project, several clinical labs will eventual…
April 4, 2022, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
On March 22, the U.S. Health Resources and Services Administration (HRSA) announced that its COVID-19 Uninsured Program had stopped accepting claims for related laboratory testing due to lack of sufficient funds. This development potentially affects 8.6% of the nation’s population which does…
March 14, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Telehealth proved to be popular with Medicare patients during the SARS-CoV-2 pandemic. The federal U.S. Department of Health and Human Services (HHS) reported telehealth visits for Medicare beneficiaries increased in 2020 by an incredible 63 times—from approximately 840,000 in 2019 to 52.7 m…
February 22, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Scopio Labs, a medical imaging company in Tel Aviv, recently landed $50 million in Series C venture capital funding as it moves to more fully enter the clinical laboratory market, TechCrunch reported on Feb. 9. Scopio has developed a scanner that can magnify a whole blood sample by 100 …
January 31, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
DNA-based breast cancer testing is taking a step forward. Illumina in San Diego, which sells next-generation sequencing (NGS) technology, announced a partnership with Agendia in Irvine, Calif., to develop in vitro diagnostic tests for oncology. Agendia offers proprietary breast …
January 10, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Imagine a medical lab temporarily closing because of the demand for too many tests! That’s just what happened at one of Australia’s largest medical lab companies. Australian Clinical Labs had to temporarily discontinue offering COVID-19 testing because test volumes had gotten too large. Au…
December 20, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
In Europe, Switzerland-based Unilabs will be acquired by a Danish company. Unilabs owns laboratories in at least 11 European countries and posted revenue of €2 billion euros (US $2.26 billion) in the financial year ending September. The seller is Apax Partners, a private equity compan…
November 29, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Pathologists interested in ways to automate the various manual steps in the histology laboratory may want to watch the progress of an emerging company. Clarapath of Hawthorne, N.Y., says it is “automating processes around the way tissue is processed onto glass slides via ‘sectioning,’ or…
November 8, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
Last week, the state of California auto-renewed its controversial COVID-19 testing contract with PerkinElmer to run the Valencia Branch Laboratory. Designed, built, and operated by PerkinElmer, the lab began SARS-CoV-2 testing in the fall of 2020 and immediately was in the news for a range of …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized